Alvotech (ALVO) Interest & Investment Income (2021 - 2026)
Alvotech's (ALVO) quarterly Interest & Investment Income came in at $33.4 million in Q1 2026, down 73.55% YoY from $126.3 million in Q1 2025, and up 20.17% on a QoQ basis from $27.8 million in Q4 2025.
Alvotech (ALVO) Interest & Investment Income (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Interest & Investment Income data on file, last reported at $33.4 million in Q1 2026.
- Quarterly Interest & Investment Income fell 73.55% year-over-year to $33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.6 million (down 48.85% YoY) and the FY2025 annual result came in at $198.5 million, up 147.67% from the prior year.
- Interest & Investment Income improved to $33.4 million in Q1 2026, from $27.8 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $126.3 million in Q1 2025 to a low of -$41.6 million in Q4 2023.
- A 5-year average of $39.3 million and a median of $27.8 million in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income tumbled 181.54% — and 2025, when it soared 16131189.91%.
- Tracing ALVO's Interest & Investment Income over 5 years: stood at $51.0 million in 2022, then plunged by 181.54% to -$41.6 million in 2023, then soared by 102.56% to $1.1 million in 2024, then soared by 2508.35% to $27.8 million in 2025, then grew by 20.17% to $33.4 million in 2026.
- The last three Interest & Investment Income figures came in at $33.4 million (Q1 2026), $27.8 million (Q4 2025), and $21.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alvotech | 1.18 Bn | 1.18 Bn | 5.09 Mn | 33.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.41 Mn |
| Dec 31, 2025 | 27.81 Mn |
| Sep 30, 2025 | 21.44 Mn |
| Jun 30, 2025 | 22.94 Mn |
| Mar 31, 2025 | 126.31 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | 80.82 Mn |
| Mar 31, 2024 | 783.00 |
| Dec 31, 2023 | -41.56 Mn |
| Aug 31, 2023 | 122.48 Mn |
| Jun 30, 2023 | 122.48 Mn |
| Mar 31, 2023 | 1,226.00 |
| Dec 31, 2022 | 50.97 Mn |
| Aug 31, 2022 | 50.97 Mn |
| Jun 30, 2022 | 50.96 Mn |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 51.56 Mn |
| Sep 30, 2021 | 3,000.00 |